Design and Development of Molecular Imaging Probes

被引:175
作者
Chen, Kai [1 ]
Chen, Xiaoyuan [2 ]
机构
[1] NIBIB, Lab Mol Imaging & Nanomed LOMIN, NIH, Bethesda, MD 20892 USA
[2] Univ So Calif, Keck Sch Med, Dept Radiol, Mol Imaging Ctr, Los Angeles, CA 90033 USA
关键词
Molecular imaging; imaging probe design; imaging probe development strategies; POSITRON-EMISSION-TOMOGRAPHY; STIMULATING HORMONE ANALOG; SMALL-ANIMAL PET; INTEGRIN ALPHA(V)BETA(3) EXPRESSION; PROTEIN-SYNTHESIS RATE; IN-VIVO; CLICK CHEMISTRY; TUMOR XENOGRAFTS; LIVING SUBJECTS; PROTEOMIC TECHNOLOGIES;
D O I
10.2174/156802610791384225
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Molecular imaging, the visualization, characterization and measurement of biological processes at the cellular, subcellular level, or even molecular level in living subjects, has rapidly gained importance in the dawning era of personalized medicine. Molecular imaging takes advantage of the traditional diagnostic imaging techniques and introduces molecular imaging probes to determine the expression of indicative molecular markers at different stages of diseases and disorders. As a key component of molecular imaging, molecular imaging probe must be able to specifically reach the target of interest in vivo while retaining long enough to be detected. A desirable molecular imaging probe with clinical translation potential is expected to have unique characteristics. Therefore, design and development of molecular imaging probe is frequently a challenging endeavor for medicinal chemists. This review summarizes the general principles of molecular imaging probe design and some fundamental strategies of molecular imaging probe development with a number of illustrative examples.
引用
收藏
页码:1227 / 1236
页数:10
相关论文
共 97 条
[1]   Perspective: A program to improve protein biomarker discovery for cancer [J].
Aebersold, R ;
Anderson, L ;
Caprioli, R ;
Druker, B ;
Hartwell, L ;
Smith, R .
JOURNAL OF PROTEOME RESEARCH, 2005, 4 (04) :1104-1109
[2]  
Asanuma D, 2009, METHODS MOL BIOL, V574, P47, DOI 10.1007/978-1-60327-321-3_5
[3]  
Avdeef Alex, 2001, Current Topics in Medicinal Chemistry, V1, P277, DOI 10.2174/1568026013395100
[4]   Synthesis and evaluation of technetium-99m-and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA) [J].
Banerjee, Sangeeta R. ;
Foss, Catherine A. ;
Castanares, Mark ;
Mease, Ronnie C. ;
Byun, Youngjoo ;
Fox, James J. ;
Hilton, John ;
Lupold, Shawn E. ;
Kozikowski, Alan P. ;
Pomper, Martin G. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (15) :4504-4517
[5]  
Beyer T, 2000, J NUCL MED, V41, P1369
[6]   Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature [J].
Cai, Weibo ;
Chen, Kai ;
Li, Zi-Bo ;
Gambhir, Sanjiv S. ;
Chen, Xiaoyuan .
JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (11) :1862-1870
[7]   Nanoplatforms for targeted molecular imaging in living subjects [J].
Cai, Weibo ;
Chen, Xiaoyuan .
SMALL, 2007, 3 (11) :1840-1854
[8]   How molecular imaging is speeding up antiangiogenic drug development [J].
Cai, Weibo ;
Rao, Jianghong ;
Gambhir, Sanjiv S. ;
Chen, Xiaoyuan .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (11) :2624-2633
[9]   Imaging of Integrins as Biomarkers for Tumor Angiogenesis [J].
Cai, Weibo ;
Niu, Gang ;
Chen, Xiaoyuan .
CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (28) :2943-2973
[10]  
Catana C, 2006, J NUCL MED, V47, P1968